3-bromo-4,5-dihydroisoxazole

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Pancreatic Neoplasms (Pancreatic Cancer) 06/05/2023 - "Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells."
2.	Neoplasms (Cancer) 04/01/2005 - "A series of 3-bromo-4,5-dihydroisoxazole compounds were prepared and tested for their ability to irreversibly inhibit human transglutaminase 2 (TG2), an enzyme that plays an important role in the pathogenesis of diverse disorders including Celiac Sprue and certain types of cancers. "
3.	Celiac Disease (Celiac Sprue) 04/01/2005 - "A series of 3-bromo-4,5-dihydroisoxazole compounds were prepared and tested for their ability to irreversibly inhibit human transglutaminase 2 (TG2), an enzyme that plays an important role in the pathogenesis of diverse disorders including Celiac Sprue and certain types of cancers. "

1.	Enzymes
2.	Protein Glutamine gamma Glutamyltransferase 2